Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VagiBIOM for Bacterial Vaginosis
NCT05060029Phase 4Unknown
- Sponsor
- Vedic Lifesciences
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 4 trial of VagiBIOM in bacterial vaginosis (BV), sponsored by Vedic Lifesciences. Status: unknown.
02
Drugs
VagiBIOM
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT05060029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060029.